J&J Shot’s Future Depends on 15 Cautious Vaccine Experts (1)

April 21, 2021, 5:24 PM

Advisers to the Centers for Disease Control and Prevention are under pressure to decide whether the U.S. can resume use of Johnson & Johnson’s Covid-19 vaccine, perhaps with some limits, 10 days into a pause on using it.

Members of CDC’s Advisory Committee on Immunization Practices will reconvene Friday to decide whether they have enough data to say who should -- or shouldn’t -- receive J&J’s shot. Options include a full resumption, restrictions by age or gender, or extending the pause.

Wilbur Chen, a voting member of the committee and a professor at the University of Maryland School of ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.